The objective of this webinar is to help participants optimise OAB management.
First, comments will be given on current guidelines on OAB management. Then, strengths and weaknesses of both therapies will be exposed including a critical review of the Rosetta study and long-term results (outcomes of both therapies and discontinuation rate of botulinum toxin A injection). Finally an interactive case will be presented in order to illustrate everyday practice.